Houston, TX, United States of America

Ryan Johnson

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2015-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryan Johnson. Retrieved from https://idiyas.com/inventor/ryan-johnson-leopgwsy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Houston, TX (US) (2015 - 2019)
  • Stafford, TX (US) (2021)

Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ryan Johnson

Introduction

Ryan Johnson is a notable inventor based in Houston, Texas, with a focus on developing innovative solutions in the field of medical science. He holds a total of four patents, showcasing his commitment to advancing healthcare technologies. His work primarily revolves around the modulation of HIF (Hypoxia-Inducible Factor) activity, which plays a crucial role in cancer treatment and other hypoxia-mediated diseases.

Latest Patents

Among his latest patents, Johnson has developed compounds and methods that may serve as inhibitors of HIF pathway activity. These inventions are aimed at the treatment or prevention of cancer and other diseases associated with hypoxia. His contributions in this area are significant, as they offer potential new avenues for therapeutic interventions.

Career Highlights

Ryan Johnson is affiliated with the University of Texas System, where he continues to engage in groundbreaking research. His academic and professional background has equipped him with the expertise necessary to innovate in the medical field. His dedication to research and development is evident in the patents he has secured.

Collaborations

Johnson collaborates with esteemed colleagues, including Philip Jones and Alessia Petrocchi. These partnerships enhance the scope of his research and contribute to the advancement of their shared goals in medical innovation.

Conclusion

In summary, Ryan Johnson is a prominent inventor whose work in HIF modulation has the potential to transform cancer treatment and address hypoxia-related diseases. His contributions to the field are invaluable, and his ongoing research promises to yield further advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…